
David J Cohen MD
Adult Congenital Heart Disease, Interventional Cardiology
Professor, Internal Medicine, University of Missouri, Kansas City School of Medicine
Join to View Full Profile
100 Port Washington BlvdSte 105Roslyn, NY 11576
Phone+1 516-390-9640
Fax+1 816-756-3645
Dr. Cohen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Beth Israel Deaconess Medical CenterFellowship, Cardiovascular Disease, 1989 - 1994
- Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 1986 - 1989
- Harvard Medical SchoolClass of 1986
Certifications & Licensure
- NY State Medical License 2020 - 2027
- MO State Medical License 2006 - 2026
- MA State Medical License 1989 - 2025
- KS State Medical License 2006 - 2022
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- 1 citationsOutcomes of Percutaneous Coronary Interventions Following Transcatheter Aortic Valve Replacement: Insights From the CathPCI Registry.Christina Lalani, Ravi K Sharma, Jonathan Sevilla-Cazes, Kevin Kennedy, Neel M Butala
The American Journal of Cardiology. 2025-09-15 - FFRangio-guided versus pressure wire-guided PCI: design and rationale of the multicentre, randomised ALL-RISE trial.Björn Redfors, Mahesh V Madhavan, Ajay J Kirtane, William F Fearon, Robert W Yeh
Eurointervention. 2025-08-18 - Lessons Learned From the ACURATE IDE Trial for Transcatheter Aortic Valve Replacement.Arturo Giordano, Giuseppe Biondi-Zoccai, David J Cohen, Rodrigo Bagur, Nicola Corcione
Catheterization and Cardiovascular Interventions. 2025-08-18
Journal Articles
- Coronary Health Status Benefits of Successful Chronic Total Occlusion Revascularization Across the Spectrum of Left Ventricular Function: Insights from the OPEN-CTO Re...David J Cohen, Sophia Airhart, J Aaron Grantham, Adam C Salisbury, James M McCabe, John A Spertus, ScienceDirect
- Original Investigation Stroke After Surgical Versus Transfemoral Transcatheter Aortic Valve Replacement in the PARTNER TrialEugene H Blackstone, Vinod H Thourani, Howard C Herrmann, David J Cohen, Martin B Leon, Michael J Mack, Raj R Makkar, Samir R Kapadia, Susheel K Kodali, Lars G Svensso..., ScienceDirect
- Original Investigations Long-Term Survival Following Multivessel Revascularization in Patients with Diabetes (FREEDOM Follow-on Study)Michael Domanski, Samin K Sharma, David J Cohen, Valentin Fuster, George D Dangas, ScienceDirect
- Join now to see all
Authored Content
- Less Is Still More in Patients with Acute Myocardial Infarction and Cardiogenic ShockAugust 2018
- Reply Cost-Effectiveness of Long-Term Ticagrelor in Patients with Prior Myocardial Infarction: Analysis by SubgroupsJanuary 2018
Press Mentions
- CRF Unveils Late-Breaking Clinical Trials and Scientific Advances for TCT 2025August 27th, 2025
- What’s in a Name: Is It Time to Choose Between TAVI and TAVR?March 27th, 2025
- Need for Rethink of Discharge Medications After LAA Closure? EMERGEMarch 12th, 2025
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: